The Reproductive Medicine Center of the Fourth Affiliated Hospital,f Zhejiang University School of Medicine, is led by Chief Expert Huang Hefeng, an academician of the Chinese Academy of Sciences, with Xu Jian, an expert receiving the Special Government Allowance of the State Council, serving as the center director. The center has 11 medical, teaching, and research experts at or above the associate senior title level, including 4 doctoral supervisors. The clinical department covers an area of approximately 10,800 square meters, featuring independent radiology and ultrasound imaging divisions, a laboratory testing division, an assisted reproduction laboratory, operating rooms, and inpatient wards. The research department, based on the International Institutes of Medicine, Zhejiang University, has an independent laboratory space of approximately 1,800 square meters, including a complete IVF research platform. With fertility preservation and promotion as its core mission, the center focuses on reproductive endocrinology, reproductive surgery, reproductive genetics, and assisted reproductive technology, as well as basic research and technological innovation oriented toward clinical problems. It is characterized by internationalization and adopts a development model of deep integration of clinical practice and research, committed to advancing innovation in reproductive medicine and striving to build a world-class reproductive medicine center.

The center focuses on common and complex refractory diseases related to reproductive disorders in both men and women. Key disease categories include premature ovarian insufficiency, polycystic ovary syndrome, menstrual disorders, uterine fibroids with infertility, endometriosis and adenomyosis with infertility, endometrial lesions and intrauterine adhesions, recurrent miscarriage, and male oligospermia, asthenospermia, or azoospermia. Its featured and advantageous technologies include a minimally invasive and non-invasive treatment system for uterine fibroids with infertility, comprehensive treatment strategies for endometriosis, focused ultrasound therapy for adenomyosis, laparoscopic tubal anastomosis, prevention and re-adhesion control techniques for intrauterine adhesions (developed under proprietary patents), micro-burst multifetal pregnancy reduction, transmyometrial embryo transfer (TMEF, a national first), and an integrated system for ovarian and uterine fertility preservation and promotion jointly developed with the Women's Hospital, School of Medicine, Zhejiang University.